Muraki Y et al. |
Impact of CYP3A5 genotype of recipients as well as donors on the tacrolimus pharmacokinetics and infectious complications after living-donor liver transplantation for Japanese adult recipients. |
2011 Oct-Dec |
Ann. Transplant. |
pmid:22210422
|
Foroncewicz B et al. |
A comparison between two tacrolimus-based immunosuppression regimens in renal transplant recipients: 7-year follow-up. |
2013 |
Ann. Transplant. |
pmid:23896824
|
Arreola-Guerra JM et al. |
Tacrolimus Trough Levels as a Risk Factor for Acute Rejection in Renal Transplant Patients. |
2016 |
Ann. Transplant. |
pmid:26879833
|
Fox BD et al. |
Tacrolimus Levels Are Not Associated with Risk of Malignancy in Lung Transplant Recipients. |
2017 |
Ann. Transplant. |
pmid:29133776
|
Legris T et al. |
Humoral immunity after kidney transplantation: impact of two randomized immunosuppressive protocols. |
2013 |
Ann. Transplant. |
pmid:24231646
|
Bäckman L and Persson CA |
An observational study evaluating tacrolimus dose, exposure, and medication adherence after conversion from twice- to once-daily tacrolimus in liver and kidney transplant recipients. |
2014 |
Ann. Transplant. |
pmid:24637379
|
Girman P et al. |
The effect of bone marrow transplantation on survival of allogeneic pancreatic islets with short-term tacrolimus conditioning in rats. |
2001 |
Ann. Transplant. |
pmid:11803619
|
Steinebrunner N et al. |
Pharmacodynamic monitoring of nuclear factor of activated T cell-regulated gene expression in liver allograft recipients on immunosuppressive therapy with calcineurin inhibitors in the course of time and correlation with acute rejection episodes--a prospective study. |
2014 |
Ann. Transplant. |
pmid:24457606
|
Wu YJ et al. |
Safe One-to-One Dosage Conversion From Twice-Daily to Once-Daily Tacrolimus in Long-Term Stable Recipients After Liver Transplantation. |
2016 |
Ann. Transplant. |
pmid:26782179
|
Gijsen VM et al. |
Tacrolimus-induced nephrotoxicity and genetic variability: a review. |
2012 Apr-Jun |
Ann. Transplant. |
pmid:22743729
|
Urbanowicz T et al. |
Induction therapy, tacrolimus plasma concentration, and duration if intensive care unit stay are risk factors for peripheral leucopenia following heart transplantation. |
2014 |
Ann. Transplant. |
pmid:25274118
|
Czubkowski P et al. |
Cardiovascular risk factors after conversion from cyclosporine to tacrolimus in children after liver transplantation. |
2014 |
Ann. Transplant. |
pmid:25409773
|
Baron PW et al. |
Post-Transplant Diabetes Mellitus After Kidney Transplant in Hispanics and Caucasians Treated with Tacrolimus-Based Immunosuppression. |
2017 |
Ann. Transplant. |
pmid:28533501
|
Aguiar D et al. |
Real-World Multicenter Experience of Immunosuppression Minimization Among 661 Liver Transplant Recipients. |
2017 |
Ann. Transplant. |
pmid:28461684
|
Roan JN et al. |
Dose-normalization for exposure to mycophenolic acid and the early clinical outcome in patients taking tacrolimus after heart transplantation. |
2013 |
Ann. Transplant. |
pmid:23792500
|
Tanaka T et al. |
Evaluation of immune function under conversion from Prograf to Advagraf in living donor liver transplantation. |
2013 |
Ann. Transplant. |
pmid:23792533
|
Ueda K et al. |
Early corticosteroid withdrawal in the real world: a long-term analysis of kidney transplant recipients from the Mycophenolic Acid Observational Renal Transplant Registry. |
2014 |
Ann. Transplant. |
pmid:24535029
|
El-Agroudy AE et al. |
Long-term graft outcome in patients with chronic allograft dysfunction after immunosuppression modifications. |
2008 |
Ann. Transplant. |
pmid:19034223
|
Augusto JF et al. |
Long-term maintenance immunosuppressive regimen with tacrolimus monotherapy. |
2013 |
Ann. Transplant. |
pmid:23872516
|
Basu A et al. |
Outcomes of renal transplantation in recipients with peak panel reactive antibody >30% under tacrolimus-based immunosuppression. |
2011 Jul-Sep |
Ann. Transplant. |
pmid:21959503
|
Zegarska J et al. |
Mycophenolic Acid Metabolites Acyl-Glucuronide and Glucoside Affect the Occurrence of Infectious Complications and Bone Marrow Dysfunction in Liver Transplant Recipients. |
2015 |
Ann. Transplant. |
pmid:26313036
|
Figurski MJ et al. |
Pharmacokinetic monitoring of mycophenolic acid in heart transplant patients: correlation the side-effects and rejections with pharmacokinetic parameters. |
2012 Jan-Mar |
Ann. Transplant. |
pmid:22466911
|
Acott P and Babel N |
BK virus replication following kidney transplant: does the choice of immunosuppressive regimen influence outcomes? |
2012 Jan-Mar |
Ann. Transplant. |
pmid:22466913
|
Bułanowski M et al. |
Influence of conversion from cyclosporine A to tacrolimus on insulin sensitivity assessed by euglicaemic hyperinsulinemic clamp technique in patients after kidney transplantation. |
2012 Jul-Sep |
Ann. Transplant. |
pmid:23018257
|
Schmid S et al. |
Volatility of serum creatinine relative to tacrolimus levels predicts kidney transplant rejection. |
2014 |
Ann. Transplant. |
pmid:25123847
|
Baran DA and Galin ID |
"One size fits all": immunosuppression in cardiac transplantation. |
2003 |
Ann. Transplant. |
pmid:12848376
|
Remiszewski P et al. |
Orthotopic liver transplantation for acute liver failure resulting from "acute fatty liver of pregnancy". |
2003 |
Ann. Transplant. |
pmid:15114933
|
Eguchi S et al. |
Intentional conversion from tacrolimus to cyclosporine for HCV-positive patients on preemptive interferon therapy after living donor liver transplantation. |
2007 |
Ann. Transplant. |
pmid:18344932
|
Zahn A et al. |
Mycophenolate mofetil combination therapy improves survival after liver transplantation. A single-center retrospective analysis. |
2013 |
Ann. Transplant. |
pmid:24088725
|
Garaix F et al. |
Tacrolimus Granules for Oral Suspension as Post-Transplant Immunosuppression in Routine Medical Practice in France: The OPTIMOD Study. |
2018 |
Ann. Transplant. |
pmid:30093607
|
WÅ‚odarczyk Z et al. |
Freedom from rejection and stable kidney function are excellent criteria for steroid withdrawal in tacrolimus-treated kidney transplant recipients. |
2002 |
Ann. Transplant. |
pmid:12465429
|
Matia I et al. |
Immunosuppressive protocol with delayed use of low-dose tacrolimus after aortic transplantation suppresses donor-specific anti-MHC class I and class II antibody production in rats. |
2014 |
Ann. Transplant. |
pmid:24815872
|
Gardiner KM et al. |
Multinational Evaluation of Mycophenolic Acid, Tacrolimus, Cyclosporin, Sirolimus, and Everolimus Utilization. |
2016 |
Ann. Transplant. |
pmid:26729299
|
Park S et al. |
Reduced Tacrolimus Trough Level Is Reflected by Estimated Glomerular Filtration Rate (eGFR) Changes in Stable Renal Transplantation Recipients: Results of the OPTIMUM Phase 3 Randomized Controlled Study. |
2018 |
Ann. Transplant. |
pmid:29891834
|
Jannot M et al. |
Early conversion from twice-daily tacrolimus to once-daily extended formulation in renal transplant patients before hospital discharge. |
2014 |
Ann. Transplant. |
pmid:24999809
|
Urbanowicz T et al. |
Comparison of conventional tacrolimus versus prolong release formula as initial therapy in heart transplantation. |
2014 |
Ann. Transplant. |
pmid:24949728
|
Tang JT et al. |
A Low Fixed Tacrolimus Starting Dose Is Effective and Safe in Chinese Renal Transplantation Recipients. |
2018 |
Ann. Transplant. |
pmid:29735966
|
Fuchs U et al. |
Incidence of malignant neoplasia after heart transplantation--a comparison between cyclosporine a and tacrolimus. |
2014 |
Ann. Transplant. |
pmid:24953848
|
Hošková L et al. |
Comparison of Cystatin C and NGAL in Early Diagnosis of Acute Kidney Injury After Heart Transplantation. |
2016 |
Ann. Transplant. |
pmid:27226081
|
Abdel Halim M et al. |
Toxic tacrolimus blood levels with rifampin administration in a renal transplant recipient. |
2010 Jan-Mar |
Ann. Transplant. |
pmid:20305320
|
Foroncewicz B et al. |
Cyclosporine is superior to tacrolimus in liver transplant recipients with recurrent psoriasis. |
2014 |
Ann. Transplant. |
pmid:25163829
|
Bösmüller C et al. |
Tacrolimus monotherapy following alemtuzumab induction in combined kidney-pancreas transplantation: results of a prospective randomized trial. |
2012 |
Ann. Transplant. |
pmid:23274323
|
Olczak-Kowalczyk D et al. |
The status of dental and jaw bones in children and adolescents after kidney and liver transplantation. |
2012 |
Ann. Transplant. |
pmid:23274327
|
Zakliczyński M et al. |
Clinical application of monitoring mycophenolic acid trough concentration in heart transplant recipients--single center's experience. |
2005 |
Ann. Transplant. |
pmid:16218032
|
Mahalati K and Kahan BD |
Pharmacological surrogates of allograft outcome. |
2000 |
Ann. Transplant. |
pmid:11217202
|
Ruangkanchanasetr P et al. |
Beta Cell Function and Insulin Resistance After Conversion from Tacrolimus Twice-Daily to Extended-Release Tacrolimus Once-Daily in Stable Renal Transplant Recipients. |
2016 |
Ann. Transplant. |
pmid:27980321
|
Malinowski M et al. |
The influence of commonly used immunosuppressive drugs on the small bowel functions - a comparative experimental study. |
2009 Apr-Jun |
Ann. Transplant. |
pmid:19487793
|
Kitazawa F et al. |
Pharmacokinetic Interaction Between Tacrolimus and Fentanyl in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation. |
2017 |
Ann. Transplant. |
pmid:28947731
|
Kishida N et al. |
Increased Incidence of Thrombotic Microangiopathy After ABO-Incompatible Living Donor Liver Transplantation. |
2016 |
Ann. Transplant. |
pmid:27956735
|
Hirano Y et al. |
Prolonged Administration of Twice-Daily Bolus Intravenous Tacrolimus in the Early Phase After Lung Transplantation. |
2017 |
Ann. Transplant. |
pmid:28798289
|
Illsinger S et al. |
Effect of tacrolimus on energy metabolism in human umbilical endothelial cells. |
2011 Apr-Jun |
Ann. Transplant. |
pmid:21716189
|
Duvoux C et al. |
Sustained virological response to antiviral therapy in a randomized trial of cyclosporine versus tacrolimus in liver transplant patients with recurrent hepatitis C infection. |
2015 |
Ann. Transplant. |
pmid:25588713
|
Mijal J et al. |
Formation of synapses between dendritic cells and lymphocytes in skin lymph in an allogeneic reaction. |
2002 |
Ann. Transplant. |
pmid:12854345
|
Albano L et al. |
Dosing of Enteric-Coated Mycophenolate Sodium Under Routine Conditions: An Observational, Multicenter Study in Kidney Transplantation. |
2016 |
Ann. Transplant. |
pmid:27122116
|
Snell GI et al. |
Evolution to twice daily bolus intravenous tacrolimus: optimizing efficacy and safety of calcineurin inhibitor delivery early post lung transplant. |
2013 |
Ann. Transplant. |
pmid:23921892
|
Wyzgał J et al. |
Insulin resistance in kidney allograft recipients treated with calcineurin inhibitors. |
2007 |
Ann. Transplant. |
pmid:18173063
|
Holechek MJ |
Medication review: FK 506. |
1991 |
ANNA J |
pmid:1708982
|
Schmid FX |
Prolyl isomerase: enzymatic catalysis of slow protein-folding reactions. |
1993 |
Annu Rev Biophys Biomol Struct |
pmid:7688608
|
Sigal NH and Dumont FJ |
Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction. |
1992 |
Annu. Rev. Immunol. |
pmid:1375473
|
Tzakis AG et al. |
Intestinal transplantation. |
1994 |
Annu. Rev. Med. |
pmid:7515221
|
Hanauer SB and Dassopoulos T |
Evolving treatment strategies for inflammatory bowel disease. |
2001 |
Annu. Rev. Med. |
pmid:11160781
|
Pratt WB |
The role of the hsp90-based chaperone system in signal transduction by nuclear receptors and receptors signaling via MAP kinase. |
1997 |
Annu. Rev. Pharmacol. Toxicol. |
pmid:9131255
|
Nikitin AV |
[Mechanisms of nephrotoxic action of immunodepressants, calcineurine inhibitors]. |
2014 |
Antibiot. Khimioter. |
pmid:25051716
|
Romano S et al. |
FK506 binding proteins as targets in anticancer therapy. |
2010 |
Anticancer Agents Med Chem |
pmid:21182472
|
Epand RF and Epand RM |
The new potent immunosuppressant FK-506 reverses multidrug resistance in Chinese hamster ovary cells. |
1991 |
Anticancer Drug Des. |
pmid:1714737
|
Jachez B et al. |
Reversion of the P-glycoprotein-mediated multidrug resistance of cancer cells by FK-506 derivatives. |
1993 |
Anticancer Drugs |
pmid:7683935
|
Yamamoto M et al. |
Cyclosporin A and FK506 reverse anthracycline resistance by altering the cell cycle. |
1995 |
Anticancer Drugs |
pmid:7579561
|
Pourtier-Manzanedo A et al. |
FK-506 (fujimycin) reverses the multidrug resistance of tumor cells in vitro. |
1991 |
Anticancer Drugs |
pmid:1724925
|
Mizuno K et al. |
Modulation of multidrug resistance by immunosuppressive agents: cyclosporin analogues, FK506 and mizoribine. |
1992 Jan-Feb |
Anticancer Res. |
pmid:1373592
|
Pinsk V et al. |
Complete Reversion of Familial Adenomatous Polyposis Phenotype Associated with Tacrolimus and Mycophenolate Mofetil Treatment Following Kidney Transplantation. |
2017 |
Anticancer Res. |
pmid:28551651
|
Kalas W et al. |
FK506 restores sensitivity of thymic lymphomas to calcium-mediated apoptosis and the inducible expression of Fas ligand. |
2003 Mar-Apr |
Anticancer Res. |
pmid:12820430
|
Harada N et al. |
Serum Asunaprevir and Daclatasvir Concentrations and Outcomes in Patients with Recurrent Hepatitis C Who Have Undergone Living Donor Liver Transplantation. |
2018 |
Anticancer Res. |
pmid:30194210
|
Ling G et al. |
Mycophenolate Mofetil Alone and in Combination with Tacrolimus Inhibits the Proliferation of HT-29 Human Colonic Adenocarcinoma Cell Line and Might Interfere with Colonic Tumorigenesis. |
2018 |
Anticancer Res. |
pmid:29848681
|
Morisaki T et al. |
A combination of cyclosporin-A (CsA) and interferon-gamma (INF-gamma) induces apoptosis in human gastric carcinoma cells. |
2000 Sep- Oct |
Anticancer Res. |
pmid:11131636
|
Gornet JM et al. |
Severe CPT-11-induced diarrhea in presence of FK-506 following liver transplantation for hepatocellular carcinoma. |
2001 Nov-Dec |
Anticancer Res. |
pmid:11911319
|
Gauthier C et al. |
Functional similarities and differences between Candida albicans Cdr1p and Cdr2p transporters. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12709320
|
Steinbach WJ et al. |
Calcineurin inhibition or mutation enhances cell wall inhibitors against Aspergillus fumigatus. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17502415
|
Gao L et al. |
Synergistic Effects of Tacrolimus and Azoles against Exophiala dermatitidis. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28923863
|
Morikawa K et al. |
Immunomodulatory effects of three macrolides, midecamycin acetate, josamycin, and clarithromycin, on human T-lymphocyte function in vitro. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7532933
|
Steinbach WJ et al. |
In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15105118
|
Onyewu C et al. |
Targeting the calcineurin pathway enhances ergosterol biosynthesis inhibitors against Trichophyton mentagrophytes in vitro and in a human skin infection model. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17664323
|
Lamoth F et al. |
In vitro activity of calcineurin and heat shock protein 90 Inhibitors against Aspergillus fumigatus azole- and echinocandin-resistant strains. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23165466
|
Onyewu C et al. |
Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12604527
|
Fortwendel JR et al. |
Differential effects of inhibiting chitin and 1,3-{beta}-D-glucan synthesis in ras and calcineurin mutants of Aspergillus fumigatus. |
2009 |
Antimicrob. Agents Chemother. |
pmid:19015336
|
Lamping E et al. |
Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei. |
2009 |
Antimicrob. Agents Chemother. |
pmid:19015352
|
Reedy JL et al. |
Immunotherapy with tacrolimus (FK506) does not select for resistance to calcineurin inhibitors in Candida albicans isolates from liver transplant patients. |
2006 |
Antimicrob. Agents Chemother. |
pmid:16569889
|
Sun S et al. |
In vitro interactions between tacrolimus and azoles against Candida albicans determined by different methods. |
2008 |
Antimicrob. Agents Chemother. |
pmid:18056277
|
Kontoyiannis DP et al. |
Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis. |
2008 |
Antimicrob. Agents Chemother. |
pmid:18070977
|
Hashemizadeh Z et al. |
Observational Study of Associations between Voriconazole Therapeutic Drug Monitoring, Toxicity, and Outcome in Liver Transplant Patients. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28923870
|
Ricardo E et al. |
In vivo and in vitro acquisition of resistance to voriconazole by Candida krusei. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24867987
|
Odom A et al. |
The immunosuppressant FK506 and its nonimmunosuppressive analog L-685,818 are toxic to Cryptococcus neoformans by inhibition of a common target protein. |
1997 |
Antimicrob. Agents Chemother. |
pmid:8980772
|
Roy J et al. |
The immunosuppressant rapamycin represses human immunodeficiency virus type 1 replication. |
2002 |
Antimicrob. Agents Chemother. |
pmid:12384349
|
Steinbach WJ et al. |
In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus isolates from transplant and nontransplant patients. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15561883
|
Sugita T et al. |
A new calcineurin inhibitor, pimecrolimus, inhibits the growth of Malassezia spp. |
2006 |
Antimicrob. Agents Chemother. |
pmid:16870799
|
Dang W et al. |
Inhibition of Calcineurin or IMP Dehydrogenase Exerts Moderate to Potent Antiviral Activity against Norovirus Replication. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28807916
|
Aoki Y and Kao PN |
Erythromycin inhibits transcriptional activation of NF-kappaB, but not NFAT, through calcineurin-independent signaling in T cells. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10543746
|
Dannaoui E et al. |
In vitro interactions between antifungals and immunosuppressive drugs against zygomycetes. |
2009 |
Antimicrob. Agents Chemother. |
pmid:19451295
|
Rivosecchi RM et al. |
Effects of Isavuconazole on the Plasma Concentrations of Tacrolimus among Solid-Organ Transplant Patients. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28674051
|
Rosenwirth B et al. |
Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analog. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7527198
|
Venkataramanan R et al. |
Voriconazole inhibition of the metabolism of tacrolimus in a liver transplant recipient and in human liver microsomes. |
2002 |
Antimicrob. Agents Chemother. |
pmid:12183280
|